General Information of Drug Transporter (DT)
DT ID DTD0334 Transporter Info
Gene Name SLC38A7
Transporter Name Putative sodium-coupled neutral amino acid transporter 7
Gene ID
55238
UniProt ID
Q9NVC3
Post-Translational Modification of This DT
Overview of SLC38A7 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-S-nitrosylation X: Amino Acid

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A7 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

5

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Serine 5 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A7 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

11

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Serine 11 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A7 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Serine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A7 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

28

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Serine 28 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A7 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

192

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Serine 192 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A7 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Threonine 17 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A7 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

33

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Threonine 33 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A7 [2] , [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

10

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A7 Tyrosine 10 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A7 [11]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

30

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC38A7 Cystine 30 has the potential to affect its expression or activity.
References
1 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
2 Multidimensional strategy for sensitive phosphoproteomics incorporating protein prefractionation combined with SIMAC, HILIC, and TiO(2) chromatography applied to proximal EGF signaling. J Proteome Res. 2011 Dec 2;10(12):5383-97.
3 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
4 Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
5 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
6 Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
7 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
9 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
10 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
11 Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.